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Background: Patients who undergo lumbar disc surgery for herniated discs, are advocated two different postoperative
management strategies: a watchful waiting policy, or referral for rehabilitation immediately after discharge from the
hospital. A direct comparison of the effectiveness and cost-effectiveness of these two strategies is lacking.
Methods/Design: A randomised controlled trial will be conducted with an economic evaluation alongside to
assess the (cost-) effectiveness of rehabilitation after lumbar disc surgery. Two hundred patients aged 18–70 years
with a clear indication for lumbar disc surgery of a single level herniated disc will be recruited and randomly
assigned to either a watchful waiting policy for first six weeks or exercise therapy starting immediately after
discharge from the hospital. Exercise therapy will focus on resumption of activities of daily living and return to
work. Therapists will tailor the intervention to the individual patient’s needs. All patients will be followed up by the
neurosurgeon six weeks postoperatively. Main outcome measures are: functional status, pain intensity and global
perceived recovery. Questionnaires will be completed preoperatively and at 3, 6, 9, 12 and 26 weeks after surgery.
Data will be analysed according to the intention-to-treat principle, using a linear mixed model for continuous
outcomes and a generalised mixed model for dichotomous outcomes. The economic evaluation will be
performed from a societal perspective.
Discussion: The results of this trial may lead to a more consistent postoperative strategy for patients who will
undergo lumbar disc surgery.
Trial registration: Netherlands Trial Register: NTR3156
Keywords: Rehabilitation, Exercise, Physiotherapy, Lumbar disc surgery, Lumbar disc herniation, Randomised
controlled trial, Economic evaluationBackground
The lumbosacral radicular syndrome, also called sciatica,
is commonly caused by a herniated disc [1]. The syn-
drome is characterised by lower limb pain radiating be-
low the knee in an area of the leg served by one or more
lumbosacral nerve roots. Sometimes there are neurolo-
gical phenomena such as sensory and motor deficits. In
the Netherlands, the incidence of sciatica increased from* Correspondence: t.oosterhuis@vu.nl
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distribution, and reproduction in any medium75,000 to 85,000 cases per year over the past decade [2,3].
The direct and indirect costs of patients suffering from
sciatica approximate 1.2 billion Euros per year [2]. The
natural course of sciatica is favourable in the majority of
patients [4]. The international consensus is that surgical
treatment is offered if the radiating leg pain persists des-
pite a period of conservative management [5]. It is esti-
mated that about 12,000 operations for herniated lumbar
discs are performed in the Netherlands each year [3].
Rates of spinal surgery differ across countries and within
one country [6]. Rates in the United States are 30% higher
than in the Netherlands, 50–60% higher than in Canada
and 80% higher than in the UK [7].tral Ltd. This is an Open Access article distributed under the terms of the
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ment are equally successful [8,9]. Recovery rates between
78 and 95% were found 1–2 years postoperatively [8-13]
However, shortly after surgery results vary, with recovery
rates of 46–75% 6–8 weeks postoperatively [8,9,13] This
variation may be due to differences in defining recovery,
but also due to different referral patterns for rehabilita-
tion. It implies a poor outcome in up to 54% of the pa-
tients at short term follow up, and up to 22% of the
patients at ≥ 1 year follow up. As this group of patients
highly contributes to the direct and indirect costs of
lumbar disc surgery, an important aim of postoperative
treatment is to prevent the development of chronic
symptoms [14].
Currently, postoperative care and management, inclu-
ding referral for rehabilitation (i.e. exercise therapy and
advice provided by physiotherapists or exercise therapists),
varies between hospitals and surgeons. A national survey
in the Netherlands amongst spinal surgeons (both neu-
rosurgeons and orthopaedic surgeons) showed that 65%
of the surgeons always refer patients for postoperative
physiotherapy after discharge, whereas 24% never refer
patients for postoperative physiotherapy and 11% some-
times. Likewise, 45% of the surgeons consider physio-
therapy after discharge to be essential, but 30% of the
surgeons strongly disagree that physiotherapy would be
essential [15]. A similar trend was seen in a national survey
in the UK where 55% of the surgeons did not send their
patients for physiotherapy following spinal surgery [16]. In
another UK survey physiotherapists providing care to pa-
tients who had undergone lumbar disc surgery reported a
wide variety of treatment contents being delivered. More-
over, this study revealed considerable variation in access to
postoperative physiotherapy for outpatients [17].
Patients are usually referred for rehabilitation during
hospitalisation [15]. The two most common options for
management after discharge are continued rehabilitation
or a watchful waiting policy. The first option consists
of continued rehabilitation offered to all patients. The
second option comprises watchful waiting during the
first weeks advising to return to an active lifestyle, with
postoperative treatment only for those patients having
persisting symptoms after six to eight weeks. Several
randomised controlled trials investigated the effective-
ness of rehabilitation following primary lumbar disc sur-
gery [18]. For exercise programmes starting 4–6 weeks
postoperatively, there is moderate evidence that they are
more effective in improving physical function, and low
quality evidence that they are more effective than no
treatment in decreasing pain. There is moderate evi-
dence that high intensity exercises are more effective in
improving physical function compared to low intensity
exercises, and low quality evidence that they are more
effective in decreasing pain. However, high quality studiesassessing the effectiveness of immediate postoperative
interventions are lacking [18]. Besides, data on cost-
effectiveness of postoperative management is scarce [19].
Therefore, the aim of the Rehabilitation After Lumbar
Disc Surgery (REALISE) study is to evaluate the effective-
ness of an exercise therapy intervention starting in the
first postoperative week, compared to a watchful waiting
policy during the first 6–8 weeks after surgery. Further-
more, cost-effectiveness will be assessed by means of an
economic evaluation from a societal perspective.
Methods/Design
Design
A multicentre randomised controlled trial will be conduc-
ted, together with a full economic evaluation.
Setting
Participants will be recruited from 10 hospitals, both
urban and regional, in three regions in the Netherlands,
where lumbar disc surgery is performed. Primary care
physiotherapists and exercise therapists in the catch-
ment areas of these hospitals will provide rehabilita-
tion following this lumbar disc surgery. Prior to the
start of the trial all participating therapists will follow
a training session in which both the study design and
treatment protocol for the intervention group will be
explained.
Ethical approval
The Medical Ethics Review Board of the VU Univer-
sity Medical Centre approved the study protocol in
September 2011 (registration number NL35897.029.11).
Subsequently, local review boards of each participating
hospital approved the protocol.
Participants
Patients will be eligible for inclusion if they meet all of
the following inclusion criteria:
lumbar disc herniation confirmed by MRI and physical
signs of nerve root compression corresponding to the
level of disc herniation,
between 18 and 70 years of age,
able to fill out Dutch questionnaires themselves,
and provide written informed consent.




co-morbidities of the lumbar spine (e.g., fractures,
carcinomas, osteoporosis),
prior spinal surgery in the last 12 months,
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same side,
pregnancy,
or contra-indications for exercise therapy (e.g., acute
respiratory or cardiovascular complaints, acute
systemic infections).
Participant recruitment
Figure 1 comprises the flow diagram of the REALISE
trial. Neurosurgeons will inform all patients with a clear
indication for lumbar disc surgery about the study and
will refer potentially eligible participants to the research
team prior to surgery. The neurosurgeon will register
whether the patient would normally have been referred
for postoperative rehabilitation or not. A research nurse
will subsequently invite the patients for an intake pre-
ceding surgery and then check eligibility criteria and
provide details about the trial procedures. If the patient
consents to participate, baseline measurements will be
administered.
Treatment allocation
To conceal treatment allocation, randomisation lists per
hospital will be generated by computer prior to study
commencement by an independent person. To achievePatients with an indication for lu
neurosur
Initial check of eligibi
If potentially eligible, neurosu
research
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Figure 1 Flow diagram of the REALISE trial.the predetermined size of treatment and control group,
weighted block randomisation (blocks of four) will be
used. Directly after having received the completed base-
line questionnaire, the research nurse will open the next
consecutive a priori prepared numbered opaque enve-
lope containing the assigned postoperative strategy. Pa-
tients allocated to the intervention group will receive a
list of the participating therapists and are asked to make
an appointment for the first treatment session in the
first week after surgery. Within one week post-surgery
the research nurse will contact the patient to ensure that
an appointment has been made and to record the date
of the first appointment.Intervention
During hospitalisation all participants, regardless of
treatment allocation, will receive usual hospital care.
This treatment, provided by a physiotherapist or nurse,
mainly consists of providing advice and instructions for
transfers and performing activities of daily living, in pre-
paration for discharge. At discharge patients will receive a
booklet providing advice and suggestions for exercises.
These booklets are part of usual inpatient care and are
provided by the participating hospitals.mbar disc surgery attend a 
geon
lity by neurosurgeon
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Participants in the intervention group will receive a refer-
ral for post-surgery exercise therapy in primary care
starting the first week after discharge. During a six to eight
week period, participants will receive one or two exercise
therapy sessions per week, conform a treatment protocol
designed for this trial including information and advice
about rehabilitation. The six to eight week period reflects
the period before patients consult their neurosurgeon
again after the surgery. The exact duration of this period
depends on the organisation in the participating hospital
in which the patient was operated. The protocol is based
on existing protocols for primary care exercise therapy,
which were derived from a national clinical guideline [20].
The main goal is to gradually extend activities of daily li-
ving from personal care to housekeeping tasks in the short
term and return to work and prepare for sports and lei-
sure activities in the long term. In the first week, therapists
will perform physical examinations and focus treatment
on the ability and possibility to execute personal care ac-
tivities and perform transfers (e.g., bed to stand, chair to
stand) in the home situation. From the second week on-
ward, exercises will be taught with gradually increasing in-
tensity targeting limitations that were found in the initial
postoperative assessment. The exact type of exercises is
left to the therapists’ discretion, based on the outcomes of
the physical examination and taking patients’ preferences
into account. Therapists will provide tailored advice on
lifestyle and the execution of activities of daily living. Exer-
cises will aim to prepare for and support the resumption
of daily activities. Treatment can be terminated before the
end of the six to eight week period if the patient is fully
recovered.
Per treatment session, participating therapists will fill
out a registration form including amongst others, treat-
ment goals on both a global and more specific level,
whether homework was prescribed or not and, if appli-
cable, the reason for terminating the treatment.
Control group: watchful waiting policy
Participants assigned to the control group will not receive
exercise therapy immediately after discharge from hos-
pital. Patients may consult their neurosurgeon or general
practitioner in case of recurring or increasing complaints,
but no exercise therapy or other allied health care inter-
vention will be initiated. The research nurses will limit the
extent to which they will provide advice in case they will
be called by patients allocated to the control group. To pre-
vent diminishing contrast between groups, only advice that
has been given during the clinical phase will be repeated.
Follow-up consult neurosurgeon
Six to eight weeks after discharge a follow-up consult
with the neurosurgeon will take place. Whether patientsare referred for further treatment after this follow up con-
sultation is left to the neurosurgeons’ discretion. We will
measure all health care consumption using cost question-
naires (see section on Economic evaluation below).
Outcomes
Table 1 provides an overview of the data collected dur-
ing the trial. Baseline assessments will take place several
days to several hours preoperatively, depending on usual
logistic procedures in the participating hospitals. Follow-
up measurements will take place at three days and 3, 6,
9, 12 and 26 weeks postoperatively. The study will use
standardised instruments with demonstrated validity, re-
liability and responsiveness. Outcomes will be measured
using online questionnaires, but postal questionnaires
are available if requested. The baseline measures will in-
clude demographic data (such as age, gender and educa-
tion), relevant prognostic factors and both primary and
secondary outcomes.
Prognostic factors
Prognostic factors indicating unfavourable outcome after
lumbar disc surgery include length and severity of com-
plaints preceding surgery and psychosocial factors. Com-
plications during surgery are another prognostic factor
which will be retrieved from the patient files during the
6-week assessment [21].
Primary outcome measures
The recommended core set of outcomes for low back
pain research [22] will be used, and all measures are
self-reported.
Functional status will be assessed by the Oswestry
Disability Index (ODI) [23,24]. The ODI consists of 10
questions assessing aspects of daily living, each being
scored on a six-point scale, ranging from 0–5. The total
score comprises the 10 item-scores and ranges from 0
(no difficulty) to 50 (maximal difficulty).
Pain intensity will be measured for leg pain and low
back pain on an 11-point numerical rating scale (0 = no
pain to 10 = worst imaginable pain) [25,26]. Average pain
intensity over the preceding week will be measured, for
leg pain and low back pain separately. At three days
postoperative the pain at the time of measurement will
be assessed, again for leg and back pain separately.
Global perceived recovery will be evaluated with the
seven-point Global Perceived Effect scale (GPE), ranging
from “completely recovered” to “worse than ever” [22].
This will be dichotomised into success (completely and
much recovered) and non-success (slightly recovered, no
change, slightly worse, much worse and worse than ever).
The Medical Outcome Study Short Form 12 (SF-12)
will be used to assess general health status [27,28]. The
12 items cover the dimensions physical function and
Table 1 Overview of the data collection
Outcome measures Follow-up
Baseline 3 days 1 wk 3 wk 6 wk 9 wk 12 wk 26 wk
Demographic data X
Primary outcomes
Functional status (ODI) X X X X X X
Pain intensity leg (NRS) X X X X X X X
Pain intensity back (NRS) X X X X X X X
Global perceived recovery (GPE) X X X X X
General health status (SF-12) X X X X X X
Health related quality of life (EQ-5D) X X X X X X
Secondary outcomes
Psychosocial status (ÖMPSQ) X
Fear avoidance beliefs (FABQ) X
Expectations (CEQ) X X
Pain Coping (PCI) X
Prognostic factors
Length/severity of complaints X
Surgical complications X
Economic evaluation
Absence from work (PRODISQ) X X X
Cost questionnaire X X X
ODI: Oswestry Disability Index; NRS: Numerical Rating Scale; GPE: Global Perceived Effect Scale; SF-12: Medical Outcome Study Short Form 12; EQ-D5: EuroQol;
ÖMPSQ: Örebro Musculoskeletal Pain Screening Questionnaire; FABQ: Fear-Avoidance Beliefs Questionnaire; CEQ: credibility/expectancy questionnaire; PCI: Pain
Coping Inventory; PRODISQ: Productivity and Disease Questionnaire; wk: week or weeks.
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ranging from 0–100 per dimension. Higher scores reflect
better health.
The EuroQol (EQ-D5) will be administered to assess
health related quality of life [29,30]. This instrument
evaluates 5 dimensions of quality of life on a three-point
scale (no problems, moderate problems and severe prob-
lems). Utilities based on the EQ-5D will be estimated
using the Dutch valuation tariff [31].
Costs will be measured from a societal perspective
using cost questionnaires. Only costs related to leg and
back pain are considered and will include costs of con-
tinued rehabilitation, other health care costs, patient and
family costs, and missed days of unpaid work. The cost
questionnaires and the therapists’ registrations of ses-
sions completed are also used to check compliance to
the allocated treatment and possible cross-over, i.e. re-
ceiving exercise therapy in the control group either by
means of direct access or referral.
A modified version of the Productivity and Disease
Questionnaire (PRODISQ) will be used to evaluate ab-
sence from paid work [32]. Dutch standard costs will be
used to value resource utilisation [33]. Lost productivity
costs will be estimated according to the friction cost ap-
proach [34] and the human capital approach.Secondary outcome measures
Expectations of treatment outcome will be measured using
the credibility/expectancy questionnaire (CEQ) [35,36].
The CEQ contains three nine-point credibility scales, two
expectancy scales (0–100%) and one nine-point credibility
item. Higher scores reflect more positive expectations. At
baseline, expectations of surgery outcome will be elicited.
Furthermore, to assess expectations regarding continued
rehabilitation post-surgery and the watchful waiting policy,
respectively, the reformulated CEQ item on expected suc-
cess of treatment will be used. All CEQ baseline measures
will be taken prior to treatment allocation. The CEQ will
be used to measure expectations regarding the allocated
strategy post-surgery one week postoperatively in the
watchful waiting group and following the first treatment
session in the continued rehabilitation group.
Psychosocial risk profiles will be measured with the
Örebro Musculoskeletal Pain Screening Questionnaire
(ÖMPSQ) [37-40]. The 21 items of this questionnaire
evaluate function, pain, psychological factors and fear
avoidance on 11-point scales, yielding a total score range
of 0–210. Higher scores indicate a higher risk of devel-
oping long-term problems.
Fear-avoidance beliefs will be measured with the Fear-
Avoidance Beliefs Questionnaire (FABQ) [41,42]. This
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work (FABW) (11 items) and about physical activity
(FABPA) (5 items) using seven-point scales. Sum-scores
will be calculated for FABW (7 items, range 0–42) and
for FABPA (4 items, range 0–24).
Pain coping will be assessed with the Pain Coping
Inventory (PCI) [43]. The PCI comprises 33 items, eva-
luating three active and three passive pain coping dimen-
sions on a four-point scale ranging from ‘seldom or never’
to ‘very often’.
Blinding
Neurosurgeons will be blinded for group allocation, as
randomisation and group allocation is performed after
their involvement in participant recruitment. The re-
search nurses will inform participants on treatment allo-
cation and can, therefore, not be blinded. The nature of
the postoperative strategies precludes blinding of the pa-
tient and the therapist. Besides, all measures are patient
reported outcomes, and therefore outcome assessment is
not blinded. The unequal size of intervention and con-
trol group, necessary for multilevel analysis, prevents
blinding of the researcher and the statistician involved in
outcome analyses.
Sample size
Power calculations were based on a Cochrane review
assessing the effectiveness of rehabilitation following lum-
bar disc surgery [18] and were performed for the three
main outcomes (for all: power 0.9; alpha 0.05). To detect
a clinical relevant mean difference in a multi-level analy-
sis between the continued rehabilitation group and the
watchful waiting group of 8 points on the ODI (SD 15), a
total of 165 patients is needed. To detect a difference of 2
points (SD 3) for pain (11-point NRS) a total of 105 pa-
tients is needed. For detecting a 20% difference on the
dichotomised global perceived recovery (recovered vs not
recovered) a total of 150 patients is needed. Anticipating
15% potential study withdrawal, a total of 200 patients will
be recruited. Participants will be unequally distributed
(109 intervention vs. 91 control) to allow for multilevel
analysis, taking into account the multilevel structure of
the data in the intervention group.
Data analysis
Baseline characteristics in both arms will be compared
to check if randomisation has resulted in an equal distri-
bution of the main outcome measures, prognostic fac-
tors and known confounding factors such as age, gender,
living status and educational level.
The primary analysis will be an intention-to-treat ana-
lysis. All continuous responses will be analysed in a lin-
ear mixed model with responses at baseline and 3, 6, 9,
12 and 26 weeks. If necessary, missing items within aquestionnaire will be imputed using multiple imputation
techniques. In these analyses we will take into account
the levels of neurosurgeon, primary care therapists, pa-
tient and time of measurement. The effect of interest for
the present study will be the time by treatment inter-
action. Therefore, regression coefficients with 95% confi-
dence intervals (CI) between baseline and follow up
measurements will be calculated. If appropriate, analyses
will be adjusted for patient characteristics that differ be-
tween the two groups. For the dichotomous outcomes
we will use a generalised mixed model (logit link) with
the same multilevel structure, and the effect of interest
will be the difference between groups at each time point.
Odds ratios with 95% CI between intervention and con-
trol groups will be calculated.
A per protocol analysis will be performed to estimate
the extent to which protocol deviations may bias the re-
sults. A protocol deviation is defined as receiving one or
more sessions of exercise therapy in the first six to eight
weeks after surgery in the control group, or not receiv-
ing any sessions of exercise therapy in the first six to
eight weeks postoperatively by participants in the inter-
vention group.
Economic evaluation
The economic evaluation will be performed according to
the intention-to-treat principle and from a societal per-
spective. Multiple imputation according to the MICE al-
gorithm will be used to impute missing cost and effect
data [44].
All costs will be summed for each individual patient.
Incremental cost-effectiveness ratios (ICERs) will be calcu-
lated by dividing the difference in total costs between the
two groups by the difference in effects. Bias-corrected and
accelerated bootstrapping with 5000 replications will be
done to estimate the uncertainty surrounding the ICERs.
Bootstrapped incremental cost-effect pairs will be plotted
on cost-effectiveness planes to graphically illustrate the
uncertainty around the cost-effectiveness ratios. A sum-
mary measure of the joint uncertainty of costs and effects
will be presented using cost-effectiveness acceptability
curves, which indicate the probability that the interven-
tion is cost-effective in comparison with control at differ-
ent ceiling ratios (i.e. the maximum amount of money
society is willing to pay to gain one extra unit of effect).
Sensitivity analysis on the most important cost drivers will
be performed in order to assess the robustness of the
results.
Discussion
A systematic review that summarised results of several
randomised controlled trials yielded moderate to low qua-
lity evidence for effectiveness of postoperative exercise
programmes starting 4–6 weeks after first time lumbar
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beneficial than no treatment, and high intensity exercises
may be more effective than low intensity exercises. Little
is known about the effectiveness of immediate posto-
perative interventions in these patients [18]. Besides,
knowledge about cost-effectiveness of postoperative man-
agement is scarce [19]. Therefore, the REALISE trial aims
to evaluate the effectiveness of an exercise therapy inter-
vention starting in the first postoperative week, compared
to a watchful waiting policy during the first six to eight
weeks after surgery. To that end we mainly focus on
the question whether exercise treatment leads to a
faster recovery as compared to watchful waiting during
this immediate post operative period. Furthermore, cost-
effectiveness will be assessed by means of an economic
evaluation. Treatment in the intervention group is based
on a protocol that allows therapists to provide a tailored
intervention. Also, both physiotherapists and exercise
therapist will deliver the treatment, as this reflects current
practice in the Netherlands. This will result in a variation
across treatments and will improve generalisability of the
findings. The results of this trial may lead to a more con-
sistent postoperative strategy for patients who underwent
surgery for lumbar disc herniation.
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